Imsidolimab is an investigational humanized IgG4 antibody that inhibits the function of the interleukin-36 receptor. Findings from two phase 3 trials showed skin clearance was achieved and maintained ...

The likelihood of declining surgery was increased for American Indian, Alaska Native, or other patients, Asian or Pacific Islander patients, and Black patients compared with White patients. HealthDay ...

Synthetic-based drugs such as fentanyl and methamphetamine pose the greatest risk to the US. The Drug Enforcement Administration (DEA) has released the 2024 National Drug Threat Assessment (NDTA), an ...

Rapid procedure noninferior to standard procedure for successful initiation of extended-release naltrexone. HealthDay News — For patients with opioid use disorder (OUD), a rapid procedure (RP) is ...

Use of Botox as diagnostic model for migraine headache has positive predictive value of 89.5%. HealthDay News — Diagnostic targeted Botox injections have high positive predictive value for migraine ...

Dr Michael Ganio, ASHP’s Director of Pharmacy Practice and Quality, joins me to discuss the current drug shortage crisis, which has reached new levels.

Tool included 19 variables and had good predictive accuracy, identifying those who did not qualify for palivizumab. HealthDay News — A personalized tool can predict infants at increased risk for ...

Individuals are being urged to immediately update the mobile app to version 2.7.1 or later. Tandem Diabetes Care, Inc. has released an update to the Apple iOS t:connect mobile app, used in conjunction ...

At the time of analysis, no cases of post injection delirium syndrome were reported. A once-monthly subcutaneous formulation of olanzapine (TEV-’749) was found to improve symptoms in patients with ...

The table below is a review of notable updates that occurred in April 2024 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

The sensitivity of ColoSense was 94% for detecting colorectal cancer. The Food and Drug Administration (FDA) has approved ColoSense ™, a noninvasive colorectal cancer screening test for adults ...

The Company is offering a dedicated support platform called Cycle Vita to provide individualized product support to patients. Ormalvi ™ (dichlorphenamide) has been made available by Cycle ...